[Comparison of ifosfamid with cyclophosphamide in the therapy of rat DS carcinosarcoma].
D000818:Animals; D002296:Carcinosarcoma / Q000188:drug therapy*; D055598:Chemical Phenomena; D002621:Chemistry; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use* / Q000633:toxicity; D005021:Ethylamines / Q000009:adverse effects / Q000627:therapeutic use / Q000633:toxicity; D007275:Injections, Intravenous; D007928:Lethal Dose 50; D051379:Mice; D010078:Oxazines / Q000009:adverse effects / Q000627:therapeutic use* / Q000633:toxicity; D017976:Phosphorus Acids / Q000009:adverse effects / Q000627:therapeutic use* / Q000633:toxicity; D051381:Rats; D012513:Sarcoma, Experimental / Q000188:drug therapy
D005021:Ethylamines; D010078:Oxazines; D017976:Phosphorus Acids; D003520:Cyclophosphamide
Vergleich von Ifosfamid mit Cyclophosphamid bei der Therapie des DS-Karzinosarkoms der Ratte.